Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | B3gnt7 | Rat | 1,2-dichloroethane | increases expression | ISO | B3gnt7 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of B3GNT7 mRNA | CTD | PMID:28960355 | B3gnt7 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | B3gnt7 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of B3GNT7 mRNA | CTD | PMID:17942748 | B3gnt7 | Rat | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of B3GNT7 mRNA | CTD | PMID:17557909 | B3gnt7 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | B3gnt7 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of B3GNT7 mRNA | CTD | PMID:17942748 | B3gnt7 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of B3GNT7 mRNA | CTD | PMID:34747641 | B3gnt7 | Rat | 4,4'-sulfonyldiphenol | decreases methylation | ISO | B3gnt7 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of B3GNT7 promoter | CTD | PMID:33297965 | B3gnt7 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | B3gnt7 (Mus musculus) | 6480464 | Fenretinide results in increased expression of B3GNT7 mRNA | CTD | PMID:28973697 | B3gnt7 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of B3GNT7 mRNA | CTD | PMID:24780913 | B3gnt7 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of B3GNT7 mRNA | CTD | PMID:31881176 | B3gnt7 | Rat | acrylamide | increases expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of B3GNT7 mRNA | CTD | PMID:32763439 | B3gnt7 | Rat | actinomycin D | multiple interactions | ISO | B3GNT7 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of B3GNT7 mRNA | CTD | PMID:38460933 | B3gnt7 | Rat | aflatoxin B1 | decreases methylation | ISO | B3GNT7 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of B3GNT7 polyA tail | CTD | PMID:30157460 | B3gnt7 | Rat | all-trans-retinoic acid | increases expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of B3GNT7 mRNA | CTD | PMID:23830798 | B3gnt7 | Rat | aristolochic acid A | increases expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of B3GNT7 mRNA | CTD | PMID:33212167 | B3gnt7 | Rat | benzo[a]pyrene | increases methylation | ISO | B3gnt7 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of B3GNT7 exon | CTD | PMID:27901495 | B3gnt7 | Rat | benzo[a]pyrene | decreases methylation | ISO | B3GNT7 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of B3GNT7 3' UTR and Benzo(a)pyrene results in decreased methylation of B3GNT7 promoter | CTD | PMID:27901495 | B3gnt7 | Rat | bisphenol A | decreases methylation | ISO | B3GNT7 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of B3GNT7 gene | CTD | PMID:31601247 | B3gnt7 | Rat | bisphenol A | increases expression | ISO | B3gnt7 (Mus musculus) | 6480464 | bisphenol A results in increased expression of B3GNT7 mRNA | CTD | PMID:32156529 | B3gnt7 | Rat | camptothecin | increases expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | Camptothecin results in increased expression of B3GNT7 mRNA | CTD | PMID:38460933 | B3gnt7 | Rat | cefaloridine | decreases expression | EXP | | 6480464 | Cephaloridine results in decreased expression of B3GNT7 mRNA | CTD | PMID:18500788 | B3gnt7 | Rat | CGP 52608 | multiple interactions | ISO | B3GNT7 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to B3GNT7 gene] | CTD | PMID:28238834 | B3gnt7 | Rat | cisplatin | decreases expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of B3GNT7 mRNA | CTD | PMID:27594783 | B3gnt7 | Rat | copper atom | multiple interactions | ISO | B3GNT7 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of B3GNT7 mRNA | CTD | PMID:20971185 | B3gnt7 | Rat | copper(0) | multiple interactions | ISO | B3GNT7 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of B3GNT7 mRNA | CTD | PMID:20971185 | B3gnt7 | Rat | dextran sulfate | decreases expression | ISO | B3gnt7 (Mus musculus) | 6480464 | Dextran Sulfate results in decreased expression of B3GNT7 protein | CTD | PMID:32272095 | B3gnt7 | Rat | dextran sulfate | multiple interactions | ISO | B3gnt7 (Mus musculus) | 6480464 | Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of B3GNT7 protein] | CTD | PMID:32272095 | B3gnt7 | Rat | Dibutyl phosphate | affects expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of B3GNT7 mRNA | CTD | PMID:37042841 | B3gnt7 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of B3GNT7 mRNA | CTD | PMID:21266533 | B3gnt7 | Rat | dorsomorphin | multiple interactions | ISO | B3GNT7 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | B3gnt7 | Rat | doxorubicin | decreases expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of B3GNT7 mRNA | CTD | PMID:29803840 | B3gnt7 | Rat | entinostat | increases expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | entinostat results in increased expression of B3GNT7 mRNA | CTD | PMID:26272509 | B3gnt7 | Rat | entinostat | multiple interactions | ISO | B3GNT7 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B3GNT7 mRNA | CTD | PMID:27188386 | B3gnt7 | Rat | flusilazole | affects expression | ISO | B3gnt7 (Mus musculus) | 6480464 | flusilazole affects the expression of B3GNT7 mRNA | CTD | PMID:21195148 | B3gnt7 | Rat | formaldehyde | increases expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of B3GNT7 mRNA | CTD | PMID:28937961 | B3gnt7 | Rat | gentamycin | affects expression | EXP | | 6480464 | Gentamicins affects the expression of B3GNT7 mRNA | CTD | PMID:33387578 | B3gnt7 | Rat | glycidol | increases expression | EXP | | 6480464 | glycidol results in increased expression of B3GNT7 mRNA | CTD | PMID:24915197 | B3gnt7 | Rat | hexaconazole | affects expression | ISO | B3gnt7 (Mus musculus) | 6480464 | hexaconazole affects the expression of B3GNT7 mRNA | CTD | PMID:21195148 | B3gnt7 | Rat | niclosamide | increases expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of B3GNT7 mRNA | CTD | PMID:36318118 | B3gnt7 | Rat | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of B3GNT7 mRNA | CTD | PMID:26720608 | B3gnt7 | Rat | Nutlin-3 | multiple interactions | ISO | B3GNT7 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of B3GNT7 mRNA | CTD | PMID:38460933 | B3gnt7 | Rat | panobinostat | multiple interactions | ISO | B3GNT7 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B3GNT7 mRNA | CTD | PMID:27188386 | B3gnt7 | Rat | panobinostat | increases expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | panobinostat results in increased expression of B3GNT7 mRNA | CTD | PMID:26272509 | B3gnt7 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of B3GNT7 mRNA | CTD | PMID:33387578 | B3gnt7 | Rat | poly(I:C) | multiple interactions | ISO | B3GNT7 (Homo sapiens) | 6480464 | [TL8-506 co-treated with Poly I-C] results in increased expression of B3GNT7 mRNA | CTD | PMID:35688559 | B3gnt7 | Rat | SB 431542 | multiple interactions | ISO | B3GNT7 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | B3gnt7 | Rat | sodium arsenite | increases expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of B3GNT7 mRNA | CTD | PMID:34032870 | B3gnt7 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of B3GNT7 mRNA | CTD | PMID:34492290 | B3gnt7 | Rat | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of B3GNT7 mRNA | CTD | PMID:30012374 | B3gnt7 | Rat | titanium dioxide | decreases methylation | ISO | B3gnt7 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of B3GNT7 gene | CTD | PMID:35295148 | B3gnt7 | Rat | triadimefon | affects expression | ISO | B3gnt7 (Mus musculus) | 6480464 | triadimefon affects the expression of B3GNT7 mRNA | CTD | PMID:21195148 | B3gnt7 | Rat | valproic acid | increases methylation | ISO | B3GNT7 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of B3GNT7 gene | CTD | PMID:29154799 | B3gnt7 | Rat | valproic acid | affects expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of B3GNT7 mRNA | CTD | PMID:25979313 | B3gnt7 | Rat | valproic acid | increases expression | ISO | B3GNT7 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of B3GNT7 mRNA | CTD | PMID:23179753 more ... | B3gnt7 | Rat | valproic acid | multiple interactions | ISO | B3GNT7 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B3GNT7 mRNA | CTD | PMID:27188386 | |